Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Human Gene Therapy|January 5, 1999
High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicityN Morral, R J Parks, H Zhou, et al.Human Gene Therapy|August 14, 1999
Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectorsL Pastore, N Morral, H Zhou, et al.Nature Genetics|June 1, 1994
The origin of the major cystic fibrosis mutation (delta F508) in European populationsN Morral, J Bertranpetit, X Estivill, et al.Nature Genetics|February 14, 1998
Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicityG Schiedner, N Morral, R J Parks, et al.Human Gene Therapy|August 7, 1998
Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic deliveryW K O'Neal, H Zhou, N Morral, et al.Human Genetics|December 1, 1994
Complete detection of mutations in cystic fibrosis patients of Native American originB Mercier, O Raguénès, X Estivill, et al.Human Mutation|January 1, 1996
Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markersN Morral, T Dörk, R Llevadot, et al.Proceedings of the National Academy of Sciences of the United States of America|October 27, 1999
Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboonsN Morral, W O'Neal, K Rice, et al.Pageof 3